Cabot Corporation (NYSE:CBT)‘s stock had its “hold” rating reiterated by analysts at KeyCorp in a research report issued on Wednesday, November 1st.
A number of other equities research analysts have also weighed in on the stock. Loop Capital began coverage on shares of Cabot Corporation in a report on Thursday, September 28th. They set a “hold” rating and a $59.00 price target for the company. Zacks Investment Research upgraded shares of Cabot Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, August 16th. J P Morgan Chase & Co upgraded shares of Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Tuesday, August 15th. BidaskClub downgraded shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, ValuEngine downgraded shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Friday, July 28th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $61.14.
Shares of Cabot Corporation (NYSE:CBT) opened at $60.59 on Wednesday. Cabot Corporation has a 52-week low of $50.21 and a 52-week high of $64.66. The stock has a market cap of $3,746.48, a price-to-earnings ratio of 17.65, a PEG ratio of 1.60 and a beta of 1.11. The company has a quick ratio of 1.17, a current ratio of 1.70 and a debt-to-equity ratio of 0.41.
In other news, insider Hobart Kalkstein sold 3,881 shares of Cabot Corporation stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $53.39, for a total value of $207,206.59. Following the transaction, the insider now owns 27,736 shares of the company’s stock, valued at $1,480,825.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 2.50% of the stock is owned by insiders.
Several large investors have recently modified their holdings of CBT. AJO LP boosted its stake in shares of Cabot Corporation by 196.4% in the 2nd quarter. AJO LP now owns 918,731 shares of the specialty chemicals company’s stock valued at $49,088,000 after purchasing an additional 608,799 shares in the last quarter. Deprince Race & Zollo Inc. acquired a new position in Cabot Corporation during the 2nd quarter worth about $27,643,000. BlackRock Inc. lifted its position in Cabot Corporation by 7.2% during the 2nd quarter. BlackRock Inc. now owns 7,544,005 shares of the specialty chemicals company’s stock worth $403,077,000 after buying an additional 505,594 shares in the last quarter. Earnest Partners LLC lifted its position in Cabot Corporation by 41.8% during the 2nd quarter. Earnest Partners LLC now owns 1,491,521 shares of the specialty chemicals company’s stock worth $79,692,000 after buying an additional 439,350 shares in the last quarter. Finally, BNP Paribas Arbitrage SA lifted its position in Cabot Corporation by 433.2% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 440,191 shares of the specialty chemicals company’s stock worth $24,563,000 after buying an additional 357,639 shares in the last quarter. Institutional investors own 84.77% of the company’s stock.
About Cabot Corporation
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.
Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with our FREE daily email newsletter.